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OBJECTIVES This study was conducted to test hypotheses stating that: 1) altered signaling for mitochon-
drial membrane proteins occurs during postinfarction remodeling, and 2) successful myocar-
dial adaptation relates to promotion of specific mitochondrial membrane components.
BACKGROUND Abnormalities in high-energy phosphate content and limitations in adenosine 59-
triphosphate (ATP) synthesis rate occur during the transition to contractile failure from
compensatory remodeling after left ventricular infarction. The adenine nucleotide translocator
(ANT) and F1-ATPase respectively regulate mitochondrial adenosine 59-diphosphate
(ADP)/ATP exchange and ADP-phosphorylation, which are key components of high-energy
phosphate metabolism.
METHODS Steady-state mRNA and protein expression for ANT isoform1 and the beta subunit of the
F1-ATPase (betaF1) were analyzed in myocardium remote from the infarction zone eight
weeks after left circumflex coronary artery ligation in pigs, demonstrating either successful left
ventricular remodeling (LVR, n 5 8) or congestive heart failure (CHF, n 5 4) as determined
by clinical and contractile performance parameters.
RESULTS Substantial reductions in steady-state mRNA expression for ANT1 and betaF1 relative to
normal (n 5 8) occur in CHF, p , 0.01, but not in LVR. Relative expression for both
proteins coordinated with their respective steady-state mRNA levels; CHF at 40% normal,
p , 0.05 for ANT and 70% normal for betaF1, p , 0.05.
CONCLUSIONS Maintained signaling for major mitochondrial membrane proteins occurs in association with
successful remodeling and adaptation after infarction. Reduced expression of these proteins
relates to limited ATP synthesis capacity and high energy phosphate kinetic abnormalities
previously demonstrated in CHF. These findings imply that mitochondrial processes
participate in myocardial remodeling after infarction. (J Am Coll Cardiol 2000;36:282–7) ©
2000 by the American College of Cardiology
Myocardial remodeling occurs after left ventricular (LV)
infarction in areas remote from the injury site (1,2). This
remodeling presumably represents an effort to compensate
for changes in mechanical stress caused by localized cell
death and necrosis within the infarcted myocardium. The
precise mechanisms, which cause the transition to contrac-
tile failure from compensatory ventricular remodeling, have
not been defined (1,2). Alterations in gene and protein
expression induced by changes in cardiac mechanical stretch
appear to play a major role in these processes (3,4). Changes
in expression have been related to contractile proteins as
well as components of the sarcoplasmic reticulum and
membrane receptors (2). Although abnormalities in cou-
pling between energy utilization and production might
contribute to contractile failure, neither signaling specific
mitochondrial proteins nor expression have been examined
during postinfarction myocardial remodeling.
The final component of the reaction sequence linking
carbon substrate utilization to oxidative phosphorylation is
the mitochondrial F1-F0-ATPase; this enzyme catalyzes
phosphorylation of adenosine 59-diphosphate (ADP) to
form adenosine 59-triphosphate (ATP) (5). Because the
inner mitochondrial membrane is not permeable to adenine
nucleotides, exchange of ADP for ATP produced within
the intramitochondrial matrix occurs via the adenine nucle-
otide translocator (ANT), which spans the inner mitochon-
drial membrane (5). The ANT (isoform 1) and the beta
subunit of the F1-ATPase represent major cardiac consti-
tutive mitochondrial membrane proteins. The genes regu-
lating these proteins in the heart are nuclear encoded,
coordinately expressed and developmentally regulated (6).
Furthermore, reductions in these transcript and protein
levels relate directly to the degree of myocardial dysfunction
during several pathological processes (7,8). Accordingly, we
hypothesized that alterations in signaling and expression for
these mitochondrial membrane proteins occur in remodeled
failing hearts (congestive heart failure [CHF]), and success-
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ful myocardial adaptation after infarction depends, in part,
on promotion of these components. We examined steady-
state mRNA levels for these two genes and expression for
their corresponding proteins in porcine myocardium after
LV infarction and remodeling induced by left circumflex
artery ligation. This clinically relevant experimental model
has been previously characterized with elevations in LV
systolic and diastolic wall stresses and reduced systolic
performance (9,10). These functional abnormalities are
accompanied by reductions in steady-state high energy
phosphate levels and alterations in regulation of myocardial
oxidative phosphorylation (9,10).
METHODS
All experimental procedures were approved by the Univer-
sity of Minnesota Animal Care Committee. The investiga-
tion conformed to the “Guide for the Care and Use of
Laboratory Animals” published by the US National Insti-
tutes of Health (NIH publication #85-23, revised 1985).
Infarct production by coronary ligation. This animal
model of LV remodeling (LVR) has been described in detail
previously (9,10). Briefly, young Yorkshire swine (45 days;
;10 kg) were anesthetized with sodium pentobarbital
(30 mg/kg, IV), intubated, ventilated with a respirator and
given supplemental oxygen. Arterial blood gases were main-
tained within the physiologic range by adjustments of the
respirator settings and oxygen flow. A left thoracotomy was
performed and 0.5 cm of the proximal left circumflex
coronary artery (LCX) was dissected free and completely
occluded with a ligature. After coronary ligation the animals
were observed in the open chest state for 60 min. When
ventricular fibrillation occurred, electrical defibrillation was
performed immediately. This procedure was usually success-
ful. The chest was then closed; if the heart was dilated, the
pericardium was left open. The animals were given standard
postoperative care, including analgesia, until they were
normally active. Left circumflex coronary artery occlusion
was performed in 15 pigs. Four of the 15 pigs suffered
sudden death during the first week after ligation, likely
secondary to ventricular arrhythmia. Studies were per-
formed in the remaining 11 pigs eight weeks after the LCX
occlusion.
Experimental preparation. Eleven pigs with LVR and
eight size matched normal control animals were anesthe-
tized with sodium alpha-chloralose (100 mg/kg followed by
an infusion of 20 mg/kg/h IV), intubated, ventilated with a
respirator and given supplemental oxygen. Arterial blood
gases were maintained within the physiologic range by
adjustments of the respirator settings and oxygen flow. A
sternotomy was performed and the heart suspended in a
pericardial cradle. A second heparin-filled catheter was
introduced into the LV through the apical dimple and
secured with a purse string suture.
Experimental protocol. Aortic and LV pressures were
monitored using pressure transducers (Spectramed Inc.,
Oxnard, California) positioned at midchest level and re-
corded on an eight-channel direct writing recorder (Coul-
bourne Instrument Company, Lehigh Valley, Pennsylva-
nia). Left ventricular pressure was recorded at normal and
high gain for measurement of end-diastolic pressure. After
completion of hemodynamic measurements, several myo-
cardial specimens were obtained from the left anterior
descending perfused region and rapidly frozen in liquid
nitrogen. Tissue samples were stored at 280°C for later
molecular measurements. The hearts were then excised and
fixed in 10% buffered formalin. The atria, right ventricle,
aorta and large epicardial vessels were dissected from the
LV. The infarct scar was dissected from the LV and
weighed separately from the remainder of the LV.
RNA isolation. Approximately 100 mg frozen tissue was
pulverized, homogenized and total RNA extracted with an
RNA Isolation Kit (Ambion Inc., Austin, Texas). The
purity and concentration of the RNA samples were tested
by ultraviolet absorption at A260/A280. The quality and
concentration of the RNA samples were confirmed by
electrophoresis on denatured 1% agarose gels (8).
Northern blot analysis. For Northern blot analysis, 15 mg
of RNA was denatured and electrophoresed on 1% formal-
dehyde agarose gel, transferred to a nitrocellulose transfer
membrane (Micron Separations Inc., Westboro, Massachu-
setts) and cross-linked to the membrane using an ultraviolet
cross linker. The prehybridizing and hybridizing solutions
contained 50% formamide, 13 Denhardt’s solution, 63
saline-sodium phosphate-ethylenediaminetetraacetic acid
and 1% sodium dodecyl sulfate (SDS). Complementary
DNA (cDNA) probes were labeled with [32P]dCTP by
random primer extension (PRIME-IT II, Stratagene, La
Jolla, California) and added to the hybridizing solution at
1 3 106 cpm/ml. Hybridization was carried out at 42°C for
18 h. Blots were then washed several times with a final wash
in 1 3 standard sodium citrate and 0.1% SDS at 65°C. The
relative contents of mRNAs were determined using a
PhosphorImager Model 400S and ImageQuant quantita-
tion software (Molecular Dynamics, Sunnyvale, California).
The same size area of each band was taken to measure the
intensity, and a similar area at the closest upstream position
of each band was used as background (8). The blots were
also exposed on Kodak X-omat film (Eastman Kodak Co.,
Abbreviations and Acronyms
ADP 5 adenosine 59-diphosphate
ANT 5 adenine nucleotide translocator
ATP 5 adenosine 59-triphosphate
cDNA 5 complementary DNA
CHF 5 congestive heart failure
CK 5 creatine kinase
G3PDH 5 glyceraldehol-3-phosphate dehydrogenese
LCX 5 left circumflex coronary artery
LV 5 left ventricle or ventricular
LVR 5 left ventricular remodeling
SDS 5 sodium dodecyl sulfate
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Rochester, New York) at 270°C. RNA loading was nor-
malized by comparison with the glyceraldehyol-3-
phosphate dehydrogenese (G3PDH) RNA. Adenine nucle-
otide translocator-1 mRNA levels were detected using a 1.4
kb cDNA fragment cloned from human skeletal muscle
(ATCC, Rockville, Maryland). Beta-F1-ATPase mRNA
levels were detected using a 1.8 kb cDNA fragment cloned
from human HeLa cell line (ATCC, Rockville, Maryland)
(8). To compare different mRNA levels in the same myo-
cardial sample, aliquots of 15 mg total RNA from myocar-
dium were analyzed by means of sequentially reprobing the
membranes with G3PDH, ANT-1 and beta-F1-ATPase
cDNA probes.
Western blot analysis. Frozen tissue (50 mg) was pulver-
ized and homogenized in boiling 2% SDS extract solution
containing 1 M urea and 10 mM Tris (hydroxymethyl)
aminomethane (pH 7.5). The homogenates were centri-
fuged at 2,500 g. Supernatant protein concentration was
calculated from the formula: protein (mg/ml) 5 gamma 3
A 205, where gamma is the coefficient determined by the
spectrophotometer with standard solution at ultraviolet
wavelength 205 nm. Aliquots of the aforementioned super-
natant containing 100 mg of protein were fractionated in
SDS, resolved by 12.5% polyacrylamide gels and transferred
to polyvinlidene difluoride membranes (BioRad, Hercules,
California). Rabbit antisera to rat heart ANT or rabbit
antisera to purified rat liver mitochondrial beta-F1-ATPase
were used for Western blot analyses (7). The immunoreac-
tive protein was visualized with goat anti-rabbit horseradish
peroxidase conjugate. All blots were developed with the
SuperSignal Substrate System (Pierce, Rockfort, Illinois).
Intensities for the ANT and beta-F1-ATPase bands were
performed with laser densitometric scanning for relative
quantitation among normal, LVR and CHF hearts. For the
purpose of standardization, the same amount of protein was
run in parallel lanes on SDS gel, and densitometric scanning
was performed to insure that there were no differences in the
amount of protein loaded per lane.
Data analysis. Comparisons of LVR and CHF with nor-
mal were performed using one way analysis of variance or
Dunnet’s modification of the t test (11). A value of p , 0.05
was required for significance. All values are expressed as
mean 6 standard error.
RESULTS
Anatomic data. Within the LCX ligation group, four pigs
had peripheral cyanosis or ascites and other evidence of
CHF. Based on these clinical criteria, these four animals
comprised the CHF group. The remaining seven swine
formed the LVR group. The anatomic data are summarized
in Table 1. In the seven LVR swine, the LV weight to body
weight ratio was increased 22% as compared with eight size
matched normal swine (p , 0.05). The four CHF swine
demonstrated a greater degree of hypertrophy, with the LV
weight to body weight ratio increased 48% as compared
with the respective controls (p , 0.01). In the LVR group,
scar accounted for 7% of the LV mass, while in the CHF
group scar was 12% of the LV mass. Right ventricular
weight to body weight ratios were increased in both exper-
imental groups (p , 0.01).
Hemodynamic data. Hemodynamic data are shown in
Table 2. In swine with compensated LVR, none of the
systemic hemodynamic variables were significantly different
from normal (Table 2). However, in swine with CHF, LV
systolic pressure was significantly lower and LV end-
diastolic pressure was significantly higher than normal
(Table 2, p , 0.05).
Steady-state mRNA levels. A representative Northern
blot, illustrated in Figure 1, demonstrates the bands for
ANT1, beta-F1-ATPase and G3PDH. Figure 2 summa-
rizes the steady state mRNA levels normalized to G3PDH
Table 1. Anatomic Data
n BW (kg) (g) LVW (g) LVW/BW (g/kg) RVW/BW (g/kg) ScarW (g) ScarW/LVW
Normal 8 23.4 6 3.0 63.2 6 7.1 2.7 6 0.3 0.92 6 0.09
LVR 7 25.6 6 4.7 84.4 6 9.0* 3.3 6 0.4* 1.31 6 0.09** 6.3 6 1.0 0.07 6 0.02
CHF 4 19.9 6 3.0 82.9 6 9.7* 4.0 6 0.5** 1.66 6 0.23** 10.1 6 1.3 0.12 6 0.02
Values are mean 6 SEM.
BW 5 body weight; CHF 5 congestive heart failure; LVR 5 left ventricular remodeling; LVW 5 left ventricular weight; RVW 5 right ventricular weight; ScarW 5 scar
weight.
*p , 0.05 vs. normal; **p , 0.01 vs. normal.











Normal 8 128 6 1.4 71 6 8 96 6 12 6 6 1
LVR 7 139 6 15 74 6 8 98 6 11 9 6 1
CHF 4 141 6 19 63 6 9 72 6 17** 16 6 4*
Values are mean 6 SEM.
CHF 5 congestive heart failure; LV 5 left ventricle; LVR 5 left ventricular remodeling.
*p , 0.05 in comparison with normals; **p , 0.01 in comparison with normals.
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band intensity. Normalized beta-F1-ATPase and ANT1
mRNA levels were significantly lower in the CHF group.
These levels trended higher in LVR hearts than in control,
but statistical significance was not achieved.
Protein levels. Protein levels for ANT-1 and betaF1-
ATPase were assessed semiquantitatively by Western blot-
ting. A representative Western blot is shown in Figure 3.
Relative normalized densitometric intensities are summa-
rized in Figure 4. Both ANT and beta-F1-ATPase protein
levels were decreased in the CHF group versus normal
(0.39 6 0.07 and 0.75 6 0.09, respectively, vs. 1.00 6 0.11
and 1.00 6 0.05; each p , 0.05), while values in the
remodeled hearts were not different from control (1.01 6
0.10 and 1.06 6 0.05, respectively). The relative differences
in protein levels corresponded to mRNA levels, indicating
coordination between message level and protein expression.
DISCUSSION
This study provides data that support the hypothesis that an
alteration in gene programming for inner mitochondrial
membrane proteins occurs with decompensation after myo-
cardial infarction. The present experimental model employ-
ing coronary artery occlusion is characterized by prominent
remodeling of noninfarcted myocardium. Left ventricular
chamber enlargement occurs with associated elongation and
hypertrophy of isolated myocytes on histologic examination
(9,10). Adjustments in cytosolic high energy phosphate
concentrations and in regulation of myocardial oxidative
phosphorylation accompany these morphologic and histo-
logic changes in porcine heart. Concomitant contractile
function and bioenergetic abnormalities are most prominent
in failing remodeled hearts (9,10). Remodeled hearts, ex-
hibiting LV compensation, respond normally to the stresses
of rapid pacing or catecholamine infusion (10). In contrast,
decompensated or failing remodeled hearts do not tolerate
rapid pacing and exhibit blunting in catecholamine induced
inotropy (10). Reduced catecholamine sensitivity and
Figure 1. A representative Northern blot. Each lane represents a different
heart. Lanes were loaded with 15 mg total RNA from ventricular
myocardium and probed specifically for, b-F1-ATPase, ANT-1 and
G3PDH. Samples were taken from the normal heart (N), the heart with
postinfarction left ventricular remodeling (R) without failure and the heart
with postinfarction left ventricular failure (F) (see text). ANT 5 adenine
nucleotide translocator.
Figure 2. Steady state mRNA levels. All transcript levels are relative to the
G3PDH band intensity and normalized to the lane of the normal heart.
Groups are N, normal; LVR, left ventricular remodeling and CHF,
congestive heart failure. The data indicate that a significant decrease in
these transcript levels occurs in CHF. ANT 5 adenine nucleotide
translocator.
Figure 3. Representative Western blots show relative amounts of mito-
chondrial ANT and b-F1-ATPase in left ventricular myocardium in three
different states (N, F, and R). Each lane represents a different heart.
Substantial decreases in both mitochondrial proteins occur with heart
failure (F). 43 kD protein band serves as a marker. The same amount of
total protein (100 mg) was run in parallel lanes on a SDS gel for
standardization purpose. ANT 5 adenine nucleotide translocator; F 5
heart with postinfarction left ventricular failure; N 5 normal heart; R 5
heart with postinfarction left ventricular remodeling.
Figure 4. Densitometric intensities for protein bands from Western blots
are normalized to the lane of the normal heart. The data indicate that a
significant decrease in protein expression for ANT and b-F1-ATPase
occurs in CHF. ANT 5 adenine nucleotide translocator; CHF 5
congestive heart failure; LVR 5 left ventricular remodeling; N 5 normal
heart.
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myosin-ATPase activity might contribute to these abnormal
responses. Limitation in inherent mitochondrial oxidative
capacity offers an alternative or ancillary mechanism, which
can explain the failing heart’s inability to increase the
oxidative phosphorylation rate.
Mitochondrial proteins and contractile failure. Exami-
nation of expression for the ANT and a major subunit of the
mitochondrial (F1–F0) ATPase represent a novel approach
to evaluating the bioenergetic response during myocardial
remodeling and failure. However, establishing direct caus-
ative linkage between specific mitochondrial proteins and
contractile failure represents a challenge, as several compo-
nents comprise the oxidative phosphorylation process. Sev-
eral investigators have previously tested alternative candi-
date sites for disruption of mitochondrial respiration in
remodeled myocardium remote from the infarction site
(12–14). Although the creatine kinase (CK) system has
received considerable attention, the implications of CK
abnormalities in remodeled myocardium have not been
totally defined. Neubauer and colleagues (12) found reduc-
tions in CK flux in association with reestablishment of fetal
isozyme profiles in residual intact myocardium from chron-
ically infarcted rats (12). Similar CK isoform distribution
and flux abnormalities occur in the current porcine model
(10,13). Despite these reductions, cytosolic CK fluxes in
both rat and porcine remodeled myocardium remain sub-
stantially higher than the concurrent ATP synthesis rate.
Thus, these CK enzyme system disturbances probably do
not cause limitations in ATP synthesis capacity although
they may alter the apparent kinetic characteristics of oxida-
tive phosphorylation and shift sites of respiratory control.
ANT deficiency and high energy phosphate abnormali-
ties. The ANT provides another potential site for disrup-
tion of myocardial respiration in remodeled or failing
myocardium. Deficits in myocardial ANT transcript levels,
protein content or carrier activity occur in several models of
CHF and myocardial stunning (8,15,16). Kinetic studies
performed in isolated mitochondria and using 31 phospho-
rous magnetic resonance spectroscopy in the heart in vivo
suggest that ANT deficiencies can cause alterations in
respiratory control mechanisms (7,17,18). Thus, immature
cardiac mitochondria, which are low in ANT relative to
their adult counterparts, require correspondingly higher
levels of ADP to drive respiration (7,17). Previously pub-
lished studies employing the current pig model demon-
strated substantially lower myocardial PCr/ATP and, thus,
higher ADP concentrations in CHF than in LVR or
control, despite similar rates of ATP synthesis (10). Fur-
thermore, the oxygen consumption response to inotropic
stimulation was extremely limited in CHF hearts, implying
that markedly elevated ADP concentrations are required to
maintain ambient levels of oxygen consumption. Thus,
these data support the contention that ANT deficit is linked
to the high energy phosphate abnormalities and the limited
respiratory capacity noted in CHF hearts.
Beta-F1-ATPase and myocardial oxygen consumption
rate. The current data also demonstrate a decrease in
beta-F1-ATPase protein in remodeled myocardium show-
ing evidence of contractile failure. Although protein expres-
sion does not necessarily correspond to enzyme activity, beta
subunit content does correlate with F1-ATPase activity in
isolated mitochondria (19). Studies performed in canine
myocardium in vivo show a direct relationship between
mitochondrial ATPase activity and myocardial oxygen con-
sumption rate, though not with a 1:1 stochiometry (20).
Therefore, one can logically assume that decreased beta
subunit protein content can limit ATP synthase capacity.
Such a deficit might contribute to the apparent reduction in
the dobutamine inducible rate of myocardial oxygen con-
sumption, as well to the alterations in high energy phos-
phate levels previously observed in failing pig myocardium
(10).
The relation between mitochondrial protein expression
and mRNA levels. Coordination between protein expres-
sion and steady-state mRNA levels occurs for both the
ANT and beta-F1-ATPase in this model. This implies that
regulation of these proteins depends, in part, on changes in
transcriptional rates and/or in stability of transcriptional
products. Preserved expression of these genes occurs with
successful LV compensation after infarction, while down-
regulation occurs with contractile failure in this porcine
model. The importance of mitochondrial stability and
maintenance of signaling for these prominent mitochondrial
membrane proteins has not been previously explored during
postinfarction remodeling, though preservation of these
signals occurs in association with preserved metabolic and
contractile function after ischemic injury in the isolated
perfused heart (8). The modes of regulation of the tran-
scriptional or posttranscriptional events, which determine
these transcript levels during myocardial remodeling, re-
quire elucidation. Depre and colleagues (4) have recently
shown that myocardial transcript levels for the outer mito-
chondrial membrane protein, carnitine palmitoyltransferase
I, respond to changes in mechanical stretch during myocar-
dial remodeling induced by chronic loading or unloading.
Downregulation of expression for this gene occurs in con-
junction with reestablishment of fetal isoform patterns for
myosin, specific growth factors and protooncogenes. Their
data would imply that signals or processes regulating these
factors also regulate nuclear encoded mitochondrial proteins
such as those examined in this study. However, in those
previous studies no distinction was made between successful
compensation and maladaptation.
Conclusions. In summary, the current data show that
altered accumulation of specific inner mitochondrial mem-
brane proteins occurs during myocardial remodeling that
progresses to contractile failure. These data suggest that the
mitochondrial protein response influences the direction of
adaptation during postinfarction remodeling. Lack of accu-
mulation of these proteins is consistent with abnormalities
in high energy phosphate metabolism previously observed in
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this model. However, proof that reductions in these proteins
contribute to the limitations in oxidative phosphorylation
and contractile failure will require further rigorous analyses
of the bioenergetic state at maximal performance in failing
remodeled hearts. Remodeling may also involve changes in
regulation of other mitochondrial membrane components,
which are either nuclear or mitochondrial encoded. This
study was not performed to exclude these other proteins, but
rather to focus attention on the importance of mitochondria
during remodeling. These particular proteins were chosen
for study because they have been closely linked to regulation
of myocardial oxidative phosphorylation. Furthermore, pre-
vious studies have not differentiated responses between
clinically compensated and failing remodeled myocardium.
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